Cytek Biosciences, Inc. · NASDAQ:CTKB
Jiang Wenbin exercised options for 80,062 Cytek Biosciences, Inc. shares (Form 4)
Traded May 18, 2026 · Filed May 20, 2026
On May 18, 2026, Jiang Wenbin (Director, PRESIDENT AND CEO) exercised options for 80,062 Cytek Biosciences, Inc. shares, leaving 5,477,203 shares. Filed May 20, 2026 (Form 4).
- Options exercised
- 80,062 shares
- Holding after
- 5,477,203 shares
- Trading plan
- No
- Role
- Director, PRESIDENT AND CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 18, 2026 | Common Stock | Option exercise | 7,854 | 5,430,537 | Direct | |
| May 18, 2026 | Common Stock | Shares withheld for tax | 1,913 | US$3.55 | 5,428,624 | Direct |
| May 18, 2026 | Common Stock | Option exercise | 14,733 | 5,443,357 | Direct | |
| May 18, 2026 | Common Stock | Shares withheld for tax | 3,588 | US$3.55 | 5,439,769 | Direct |
| May 18, 2026 | Common Stock | Option exercise | 19,334 | 5,459,103 | Direct | |
| May 18, 2026 | Common Stock | Shares withheld for tax | 5,032 | US$3.55 | 5,454,071 | Direct |
| May 18, 2026 | Common Stock | Option exercise | 38,141 | 5,492,212 | Direct | |
| May 18, 2026 | Common Stock | Shares withheld for tax | 15,009 | US$3.55 | 5,477,203 | Direct |